de TYPO3 News Thu, 27 Jun 2019 09:18:02 +0200 Thu, 27 Jun 2019 09:18:02 +0200 News TYPO3 EXT:news news-74 Fri, 21 Jun 2019 09:09:06 +0200 Advantage Earth NOVENTI OPEN on the way to becoming the world’s most climate-neutral tennis tournament! Munich, June 21, 2019. Sustainability is one of the core principles of NOVENTI's corporate strategy, a benchmark for corporate success and a better tomorrow. As a new strategic partner of the NOVENTI OPEN in Halle (Westphalia), it is the German healthcare market leader’s declared goal to extend these values ​​and visions to the largest tennis tournament in Germany.

"Our mission is to make the NOVENTI OPEN the most climate-neutral tennis tournament in the world," explains Dr. Hermann Sommer, CEO of NOVENTI Health SE. “We consider economic, ecological and social aspects in all our decisions – and as one of the few industry representatives in the healthcare market, we are already certified as a climate-neutral company." In concrete terms, this means that the actions of the NOVENTI Group do not leave a carbon footprint.

To minimize the environmental impact of the NOVENTI OPEN, Dr. Sommer and his team are already making a mark in the first year of the partnership: Assuming around 100,000 visitors, NOVENTI has calculated the total amount of CO2 and the food and drinks consumed during the event, and other factors that are significant for the amount of CO2. The sustainability experts at the "Fokus Zukunft" institute came up with a total of around 13,600 tonnes of CO2. NOVENTI is now compensating this factor by supporting a water project in Brazil under the authority of the United Nations. "Fokus Zukunft” will award a corresponding certificate to the strategic partner of the NOVENTI OPEN and the tournament director Ralf Weber during the quarter-finals in Halle (Westphalia).

But the eRezept experts from Munich are also making a mark besides the CO2 compensation: they have swapped the plastic cups used at the beverage stalls at the tennis tournament for sustainable, climate-friendly packaging solutions and disposable tableware made of renewable or recycled raw materials – a good conscious to go, so to speak. "We want visitors to the biggest tennis tournament in Germany to feel our commitment right there in Halle, and to get a better picture of what we stand for," explains Dr. Sommer. "That's why it's important for us today, and in the future, not only to compensate CO2, but to reduce it and ultimately avoid it – both as a company and as a partner of the NOVENTI OPEN." Ralf Weber, founder and tournament director, is delighted: "That's a great sign for our ATP tournament and for the entire region. And, of course, also for our content partnership with NOVENTI."

Since January 1, 2018, NOVENTI has compensated all CO2 emissions, and thus operates completely climate-neutrally. NOVENTI’s emissions calculated on the basis of their CO2 footprint, including the 16 locations throughout Germany, are offset by three internationally recognized climate protection projects: an award-winning cooking stove project in Ghana, an FSC sustainable forestry project in Uruguay, and a UN certified hydropower project in India. The sustainability consultancy Fokus Zukunft certified NOVENTI as a "climate-neutral company” in recognition if its commitment. In addition, NOVENTI was honored as a "Climate Sponsor 2019/2020” by the Economic Senate.

The CEO of NOVENTI, Dr. Hermann Sommer, is a member of the Economic Senate and thus NOVENTI supports the "Development and Climate Alliance" of the Development Minister, Dr. Gerd Müller, and the Economic Senate.

Further information on sustainability at NOVENTI can be found here.


news-71 Sat, 08 Jun 2019 10:37:00 +0200 Germany’s biggest healthcare provider NOVENTI takes over title sponsorship for 2019 Tournament Director Ralf Weber: “A very strong signal for the future of our tournament”Dr. Hermann Sommer, Chief Executive Officer of NOVENTI Health SE: “We are proud to be the title sponsor of this great and long-standing grass court tournament.” Halle in Westphalia (Germany). Germany’s most important ATP tennis tournament has a new title sponsor for the 27th edition which is held from June 15th to 23th 2019. In 2019, the globally renowned ATP 500 grass court event in Halle in Westphalia, Germany, will be called NOVENTI OPEN. On Saturday, June 08th, the local organiser, the Gerry Weber Management und Event GmbH & Co. OHG, and the NOVENTI group, Germany’s biggest health care provider, signed an agreement for a three-year partnership, i.e. from 2019 to 2021. “We are very happy about the cooperation which is also a very strong signal for the future of our tournament,” said Tournament Director Ralf Weber. “Thanks to this trend-setting partnership, the tournament will continue to position itself firmly as a major event.” Both parties have not disclosed any information about the financial details of the contract.

Dr. Hermann Sommer, Chief Executive Officer of NOVENTI Health SE, explained: “At NOVENTI, we work for the strengthening of the health services in Germany and thus, in particular, support owner-operated local pharmacies. Thereby, we ensure national health care. We are proud to be the title sponsor of this great and long-standing grass court tournament.”

“NOVENTI will take over the title sponsoring of the top-class ATP tennis event for 2019 and we have a very cooperative partnership” explained tournament director Ralf Weber. The parties will discuss the details of the cooperation for the years 2020 and 2021 in autumn. Weber thanked the former title sponsor, the Gerry Weber International AG, for the long-standing partnership from the start-up phase via the further development of the tournament to becoming one of the best known global tennis competitions of the ATP Tour. Again this year, the NOVENTI OPEN will be broadcast to 130 countries, more than 350 accredited journalists will report on site.

Dr. Sven Jansen, Board Member of NOVENTI Health SE explains the background of the cooperation: “Sport and health just belong together. And NOVENTI allows its customers, i.e. pharmacies, doctors and other service providers, to focus on the most important topic – on their customers. Therefore, it was an obvious step for us to take our commitment to a healthy lifestyle to a wider audience.“

The Tournament Director Ralf Weber is also very happy about the support from the players and the pros’ management agencies: “Many top players will come this year without having a contractual obligation.”

Also the record champion Roger Federer who won the tournament in Halle in Westphalia nine times immediately affirmed his support. “We always offered the players ideal surroundings to play here and to perform at their best. Halle was and is a feel good oasis for the pros, as well as for their families,” said Ralf Weber. “That is one of the reasons why we received so much encouragement from the tennis world.”

news-67 Fri, 07 Jun 2019 07:54:00 +0200 Petra Terhardt to become Managing Director of awinta GmbH Petra Terhardt will take over as Managing Director of awinta GmbH with effect from 07/01/2019. Munich, 07 June 2019. Together with Managing Directors Sven Bertram and Gordian Schöllhorn, Ms. Terhardt will take responsibility for the entire market segment. Along with the Key Account Management, Special Supply Solutions and Strategic Market Development departments, she will thus also oversee awinta GmbH’s six regional operations. Gordian Schöllhorn will henceforth focus on customer service as well as strategic themes at awinta and synergies with NOVENTI.

Ms. Terhardt is a qualified pharmacist and has many years’ experience in the healthcare and pharmacy sectors. She built her career at Sandoz Pharmaceuticals, Stada GmbH and Lauer Fischer before joining awinta GmbH at the end of 2016 as central region Managing Director, where she proved exceptionally successful. In July 2018 she became Sales Director and transferred to head office at Bietigheim Bissingen.

Awinta GmbH is a subsidiary of NOVENTI GmbH. With about 7,000 customers, awinta is market leader for pharmacy software in the German healthcare sector.

news-64 Tue, 04 Jun 2019 07:54:00 +0200 New CCIO Dr. Sven Simons NOVENTI is reinforcing its position with Pharmacy Expert Munich, 4. June 2019. The NOVENTI Group is reinforcing its top management. Dr. Sven Simons is joining the Divisional Management Board of NOVENTI Health SE as of 09/01/2018 as the CCIO (Chief Client Innovation Officer).

Dr. Simons will manage the changes from digitization for the pharmacy profession in the future and will also refine the focus of the NOVENTI Group’s products.

Dr. Simons was employed for many years at MVDA e.V., was a member of the Management Board from 2011 until 2019, and from 2015 until recently was a member of the Executive Committee and responsible for the Pharmaceutical Expertise division.

Dr. Hermann Sommer, Chairman of the Executive Board of NOVENTI Health SE explains: “As a pharmacist-owned company, we are now glad to be able to also welcome a pharmacist into our Divisional Management Board who will naturally pay attention to pharmacists and their needs with a special insight.”

Dr. Sven Simons studied pharmaceutics in Bonn and Glasgow and is a pharmacist specialized in drug information. Until recently, he managed two pharmacies together with his wife in the Sauerland region.

The NOVENTI Group is reinforcing its top management. Dr. Sven Simons is joining the Divisional Management Board of NOVENTI Health SE as of 09/01/2018 as the CCIO (Chief Client Innovation Officer).

Dr. Simons will manage the changes from digitization for the pharmacy profession in the future and will also refine the focus of the NOVENTI Group’s products.

Dr. Simons was employed for many years at MVDA e.V., was a member of the Management Board from 2011 until 2019, and from 2015 until recently was a member of the Executive Committee and responsible for the Pharmaceutical Expertise division.

Dr. Hermann Sommer, Chairman of the Executive Board of NOVENTI Health SE explains: “As a pharmacist-owned company, we are now glad to be able to also welcome a pharmacist into our Divisional Management Board who will naturally pay attention to pharmacists and their needs with a special insight.”

Dr. Sven Simons studied pharmaceutics in Bonn and Glasgow and is a pharmacist specialized in drug information. Until recently, he managed two pharmacies together with his wife in the Sauerland region.

news-62 Mon, 13 May 2019 13:18:20 +0200 pro AvO welcomes the E-Prescription Initiative from the ABDA and recommends a round table discussion for all market partners The Federal Union of German Associations of Pharmacists (ABDA) announced at its business forum last week that it is developing a patient app. This app should be geared towards forthcoming e-prescriptions. pro Apotheke vor Ort (pro AvO) warmly welcomes the ABDA initiative as a shareholder in gematik mbH to shape the design and development of standards at the federal level for the upcoming e-prescriptions.

“We are glad and think that it is absolutely right that the ABDA has received the leadership for introducing e-prescriptions. The ABDA is pursuing the same goal as we are of creating a uniform digital standard to provide patients the best possible access to medications,” says Peter Menk, Managing Director of pro AvO.

Bring all market partners to a round table discussion now
“The Pro AvO Initiative recommends that the ABDA approach all relevant market partners now to develop common standards that all patients and all pharmacies can use. All market participants should pull together so that on-site pharmacies can participate in the growing online channel to generate the greatest-possible added value for patients,” Menk says to encourage a joint approach.

Consistent design for independent patients
According to the notification from the ABDA, e-prescriptions should be able to be consistently used in a way that is neutral, free of advertising, and does not guide or control patients. The joint venture, pro AvO, also supports this fundamentally important approach for introducing e-prescriptions as Peter Menk states: “We share the goals that the ABDA has of strengthening the role of on-site pharmacies with digital options and also securing nationwide supply in the future.” pro AvO also advocates that patients keep possession of their e-prescription and independently decide on the pharmacy where they would like to fill the prescription. In pro AvO’s view, there should be no trading of data either or other use of data without explicit patient consent.

On-site pharmacy competitiveness by joining forces
In pro AvO’s view, is also important to make every effort to work together on an open solution that includes all pharmacies. This will not work with stand-alone solutions, but only with an industry-wide solution, which is what pro AvO has been advocating for since it was founded. Pharmacists expect solutions that work at all pharmacies and that offer their patients and customers the greatest amount of added value. In pro AvO’s view, this can only work by joining forces along the entire supply chain. For example, product management must be integrated, and pharmacy deliverability must be ensured for all digital solutions so that pharmacy processes can continue to function smoothly. The best way to do this is to get all relevant market partners at one table and to mutually define the necessary standards and guidelines.

news-60 Tue, 07 May 2019 06:32:00 +0200 Committed to the environment: NOVENTI awarded as a climate-neutral company The NOVENTI Group in Munich is one of the first industry representatives in the healthcare market that is operating on a completely climate-neutral basis. It has been compensating all of its CO2 emissions since January 1, 2018. Emissions from operations determined on the basis of the group company’s CO2 footprint are compensated by three internationally recognized climate protection projects: with a cook stove project in Ghana that we were awarded, with a reforestation project according to the FSC standard for sustainable forestry in Uruguay, and with a UN certified hydropower project in India. The sustainability consulting company Fokus Zukunft is now giving the NOVENTI Group an award as a “climate-neutral company” for its involvement.

Sustainability is one of the basic principles of NOVENTI’s corporate strategy and is also a benchmark for its entrepreneurial success. The NOVENTI Group complies with sustainability by a group-wide sustainability strategy: at the economic, ecological, and societal level. The group’s holistic involvement has resulted in a series of activities in the area of corporate social responsibility: for example, the group company is actively advocating against extinction of species and is offering 12 bee colonies a new home on the business premises of its companies. In addition, NOVENTI, the market leader, is continually working on optimizing its business travel, such as by using video conferences and is working on reducing material consumption in office areas. The NOVENTI Group is becoming increasingly more sustainable in mobility as well: Hybrid vehicles are being increasingly used in the group’s vehicle fleet, and employees also have the option of leasing bicycles.  
The NOVENTI Group sees climate change as the greatest challenge of our time. The goals of the World Climate Change Conference in Paris that are just as necessary as they are ambitious can only be implemented to a limited extent by political action. They are substantially dependent on more and more companies being willing to compensate their own CO2 emissions by purchasing climate protection certificates. This is why the NOVENTI Group has now had its emissions recorded and compensated by purchasing 6,700 climate protection certificates. Fokus Zukunft GmbH & Co. KG determined the climatic stress associated with the group companies as the basis for the NOVENTI Group’s climate-neutral position.

 “Handling natural resources in a responsible way and reducing CO2 emissions to protect the climate is important to us as NOVENTI,” says Dr. Hermann Sommer, Chief Executive Officer of NOVENTI Health SE. “As an international healthcare company, multi-generational management is a top priority for us. Sustainable behavior is deeply rooted into our entire group. We are obligated to make a contribution to solving worldwide climate problems. That is why I am very glad that our company is one of the first companies in our industry that is voluntarily compensating its emissions according to the Kyoto Protocol.”

As a partner of the Alliance for Development and Climate launched by the German Federal Ministry for Economic Cooperation and Development, NOVENTI supports the common objective of attracting as many companies and people in its sphere of influence as possible to the climate protection goals defined in Paris.

news-58 Thu, 14 Mar 2019 11:08:00 +0100 NOVENTI: Successful “SINNPOSIUM” in 5 cities throughout Germany Network and industry meeting about the future of pharmacies BE A “SINNFLUENCER” – This is the slogan that NOVENTI used to invite pharmacists in March to its “SINNPOSIUM” in five different cities. Many pharmacists accepted the invitation and came to our exclusive network and industry meeting about the future of pharmacies. The meetings were interesting evenings at extraordinary locations in Bremen, Berlin, Dresden, Munich, and Stuttgart. Topics of the meetings were NOVENTI’s strategic alignment, the progress of our digital strategy, as well as a keynote speech on the digital transformation and new work. The speakers were Dr. Hermann Sommer and Dr. Sven Jansen who are both members of NOVENTI’s Board of Directors and Sven Bertram who is responsible for NOVENTI’s digital strategy. The renowned trend and futurologist, Oliver Leisse, was able to be brought in for the keynote speech. Dr. Hermann Sommer: “We are very glad that so many pharmacists came to the events, and this shows us that on-site pharmacies have a great interest in mutual, digital solutions for the future.”

NOVENTI – Interaction with all healthcare participants: “The concept of me turns into us”
After a short welcome, Dr. Hermann Sommer and Dr. Sven Jansen emphasized in their presentation how important it is to NOVENTI to strengthen on-site pharmacies. “From our company’s history, it goes without saying that one of NOVENTI’s goals is to strengthen and support pharmacists as our most important core target group. We enable on-site pharmacies to successfully master the challenges of digitization. The quality of information obtained from the internet involves special risks especially in healthcare and in particular if information from the internet is not professionally curated. It is even more important that pharmacies take the role of “guides” because they are an especially important interface for clients and patients to all healthcare service providers,” says Hermann Sommer. NOVENTI is already an important player and shaper on the healthcare market because of its sales and customer numbers. The NOVENTI corporate group is the largest health care biller in Europe and has the most possible patient touch points in Germany via its customers. NOVENTI sees its role as a partner of all participants in the healthcare industry and not only for pharmacies. Dr. Hermann Sommer is sure that: “The challenges of digitization can only be successfully handled if we work together.”

NOVENTI’s digital strategy
In his presentation, Sven Bertram specifically informed participants about the progress of NOVENTI’s digital strategy. “In recent years, the behavior of customers and patients has changed drastically away from solution-oriented behavior to needs-oriented behavior independent of time and place.” This is exactly where NOVENTI’s strategy comes into play because NOVENTI supports pharmacies by solutions and by positioning pharmacists as strong partners in healthcare. Sven Bertram: “Pharmaceutical counseling and the digital world do not contradict each other but belong together. Community pharmacies are and will always remain a focus and a pivotal point of contact for patients. The in-creasing 24/7 communication is only another communication channel.” Bertram showed pharmacists what these communication channels can look like using various use cases with digital solutions from the NOVENTI OTES portfolio. An example of these solutions is callmyApo, THE German Pharmacy App, and its new version also provides patients with a clear, innovative tool for patient medication management in addition to its time-proven function of pre-ordering medication.
Sven Bertram: “We are currently adapting ourselves and our customers to future changes with our strategic alignment and a clear goal of strengthening the position of on-site pharmacies even in times of digitization – today and tomorrow.”  

Oliver Leisse gave the attendees an inspiring conclusion with a look beyond our horizons and into the future. He used many examples to make it crystal clear that: “It is a very sure thing that there will be change caused by a variety of factors. Some of the causes of change are already known, others are being identified, and some are not even on our radar yet.”

news-56 Wed, 30 Jan 2019 15:08:28 +0100 ‘PRO AvO’ partners come together to support ‘Danke, Apotheke’ (Thank you, pharmacist) campaign Combining strengths and resources, and developing innovative digital solutions for the pharmacy market together: this is the stated goal of the ‘PRO Apotheke vor Ort’ (PRO AvO) (expert local pharmacist) initiative which was launched in December 2018 by the five well-known companies BD Rowa Germany GmbH, GEHE Pharma Handel GmbH, NOVENTI Group, Sanacorp and the Wort & Bild publishing group.

The five strong partners are launching the emotional, highly acclaimed ‘Danke, Apotheke’ pharmacist campaign on various channels. The advert will be broadcast on television and social media. Sanacorp will also provide pharmacy shops with their own promotional stand-up displays. BD Rowa will add the advert to the advertising loop on their pharmacy screens and thus reach over 1.5 million pharmacy customers throughout Germany. GEHE and Sanacorp are distributing 650,000 ‘Danke, Apotheke’ postcards to pharmacy shops. The NOVENTI Group will display the adverts prominently on their APO-TIPP customer monitors in German pharmacy shops.

‘The goal of our new initiative is to boost local pharmacies. The ‘Danke, Apotheke’ information campaign informs consumers, patients and policy makers about the wide range of services provided by pharmacists for the comprehensive provision of medicines, which are provided in a friendly, approachable manner around the clock,’ says Dr Peter Schreiner, Chairman of the Board at GEHE.

‘All PRO AvO partners immediately confirmed their support for the campaign and have agreed to demonstrate the high importance of personal consultation, reliability and credibility in health care across all of the channels available to them,’ says Peter Menk, managing director of the PRO AvO initiative.

The ‘Danke, Apotheke’ campaign shows the essential services provided by pharmacies in the provision of medicines in an authentic, emotional way. ‘Danke, Apotheke’ has won multiple awards, including the Superbrands® award for outstanding brand management and the expopharm special media award (see for more information).

About the PRO AvO initiative
The current supporters of the PRO AvO initiative are BD Rowa Germany GmbH, GEHE Pharma Handel GmbH, the NOVENTI Group, Sanacorp eG and the Wort & Bild publishing group. The goal of the initiative is to develop, in close collaboration with other participants, associations and pharmacies, a concept which gives pharmacies the option of a common standard, be it in the form of a marketplace, a platform or just a special application. The best approach for German patients is to combine the resources required for this.

news-54 Thu, 24 Jan 2019 06:57:00 +0100 The PRO AvO Initiative Gains Peter Menk as Managing Director The PRO AvO (PRO on-site pharmacy) Initiative to strengthen owner-operated pharmacies and to harmonize pharmacists’ digital applications is picking up speed. The five founding members BD Rowa Germany GmbH, GEHE Pharma Handel GmbH, NOVENTI Group, Sanacorp eG, and Wort & Bild Verlagsgruppe are appointing Peter Menk as the new managing director.

“We founded PRO AvO to develop a concept for independent, local pharmacies. With Peter Menk, we have found the ideal candidate who will press ahead with our idea and implement it with his specific and extensive expertise,” says Frank Hennings happily, executive board member of Sanacorp.

Experienced pharmacy expert for concept development and digitization
Peter Menk (49) has been active for more than 15 years in various functions on the pharmacy market. He is a former business consultant who set up one of the first nationwide pharmacy cooperations with partner pharmacies in 2003. Menk and a large advertising agency also founded their own healthcare subsidiary and converted a successful treatment concept for alternative practitioners and physicians into modern multi-channel customer communication. Peter Menk has first-hand experience with pharmacists’ worries. He helps his wife, a pharmacist, run their two pharmacies in Hamburg and has already successfully implemented his own pharmacy app there as well as social media activities.

Using digitization to strengthen on-site pharmacies
Many pharmacies see digitization as a threat because nowadays individual on-site pharmacies are inferior to the large online giants or to foreign mail-order pharmacies. This causes fears and especially leads to pharmacists demanding that, “something has to be done.”
“Above all, we see digitization as a great opportunity for on-site pharmacies,” says Peter Menk. “While mail order companies are trying everything to have direct contact with customers, German pharmacies already have an extensive, very functional, secure supply network.” Every day almost four million people come into pharmacies, and pharmacy courier services make more than 250,000 deliveries. “We have the best basis to make digitization options usable for all pharmacies – by customer focus, cooperation, and creativity,” says Menk.

What is the focus of PRO AvO?
The goal of the initiative is to give customers and pharmacies security in the digital world as well. To do this, digital ideas and applications that are being formed everywhere on the market will be harmonized and further developed, and market standards will be formulated. Ultimately, a digital solution is to be formed that offers on-site pharmacies and patients a platform that is just as secure and trustworthy as the red pharmacy “A” has been for many years in the stationary world. For many stakeholders, the understanding has grown in recent weeks and months that only a mutual solution that is open to everyone and geared toward the interests of customers and pharmacists has the opportunity to sustainably strengthen local pharmacies, which makes a unique opportunity for on-site pharmacies.

news-52 Thu, 06 Dec 2018 16:54:20 +0100 Digitization: New Initiative Launched to Strengthen On-Site Pharmacies Five strong partners, one goal Five renowned companies are founding the “PRO AvO” (PRO on-site pharmacy) initiative to strengthen owner-operated pharmacies and to harmonize pharmacists’ digital applications. One thing unites the participants in the new initiative: they are combining strengths and resources serving local pharmacies. This has laid the cornerstone for many innovative companies to collaborate to develop a new solution and implement it together with other partners.

Developing the necessary expertise and size together
The current supporters are BD Rowa Germany GmbH, GEHE Pharma Handel GmbH, NOVENTI Health SE, Sanacorp eG, and Wort & Bild Verlagsgruppe. The goal of the initiative is to create a concept in close cooperation with other participants, associations, and pharmacists that gives pharmacists the opportunity to have a mutual standard whether it is as a marketplace, platform, or only as a special application. The most promising way to do this appears to be to bundle the resources that are necessary to create the concept. “There are so many that have shown interest in this sort of a campaign that we just had to start. The decisive factor is that by themselves no one on the market can establish something that is really a sustainable benefit to pharmacists, end-users, and patients,” says Dr. Hermann Sommer, CEO of NOVENTI Health SE.

Quality and security for pharmacies geared towards clients
The new initiative is in the conceptual phase. “In the current situation, it is first and foremost about quality and security for pharmacies and a clear focus on customer needs,” emphasizes Andreas Arntzen, CEO of Wort & Bild Verlagsgruppe. Customers are requesting a digital answer where they can find all relevant information about medicinal products and pharmacies. It is also crucial that this sort of initiative be open to everyone.

For many stakeholders, the understanding has grown in recent weeks and months that only a mutual solution that is open to everyone and geared toward the interests of customers and pharmacists has the opportunity to sustainably strengthen local pharmacies, which makes a unique opportunity for on-site pharmacies.

Information about the five partners (in alphabetical order):

Rowa® Technologies by Becton Dickinson (BD) is automating warehouses and medication distribution of pharmacies and other healthcare institutions. With more than 8000 systems worldwide, the Rowa brand stands for quality and dependability that is, “made in Germany.” BD is a global technology company that is promoting preventive healthcare by improving research, diagnostics, and care. BD employees over 65,000 employees in 50 countries. Rowa Technologies is managed from Kelberg (Eifel), Germany with approximately 750 employees.

GEHE Pharma Handel GmbH is a pharmaceutical wholesale company and is a subsidiary of McKesson Europe. From 18 places of business, GEHE supplies pharmacies with medical products every day throughout Germany and contributes to secure pharmaceutical supply in Germany. Based in Stuttgart, Germany, GEHE is a pharmaceutical distributor that assists its customers with services in pharmacy management and marketing via the pharmacy cooperation called “live healthy” that is the leading pharmacy cooperation in Germany with 2,100 members and more than 60 industry partners.

As a holding company, NOVENTI combines many separate individual companies that have one thing in common: they all operate in the healthcare market with the core target groups of pharmacies, other service providers, care services, and physicians. In addition to financing security, NOVENTI offers its network platform, which promotes important cross-company transfer of expertise. At the same time, the individual companies operate separately. Group sales are currently at about 156 million euros. Over 1,900 employees contribute to the success of the entire NOVENTI Group. This also includes being repeatedly given the award of being a great place to work.

Sanacorp and its corporations achieved annual sales in their operational business of 4.5 billion euros in 2017 and are one of the largest pharmacy-specific pharmaceutical wholesale companies in Germany. With around 3,000 employees at 17 places of business, this pharmacy company ensures that around 7,500 pharmacies throughout Germany are securely and dependably supplied with medicinal and healthcare products around the clock. On top of this, the “mea® - my pharmacy” pharmacy cooperation offers attractive marketing campaigns to its members. Sanacorp eG Pharmazeutische Grosshandlung and all members of the pharmacy cooperative are at the head of the group company. The company emphatically advocates for strengthening owner-operated individual pharmacies in Germany.

Wort & Bild Verlag is the leading provider of popular healthcare media in Germany. Its print titles reach 22 million readers, and its online platforms receive over 18 million visits per month. Direct user value for the health of readers and expert pharmacy advice are always the focus. Wort & Bild Verlag publishes the following magazines: Apotheken Umschau [Pharmacy Review] (9,185,378 copies sold monthly according to IVW III/2018), Baby und Familie [Baby and Family] (666,642 copies sold monthly), Diabetes Ratgeber [Diabetes Guide] (1,171,058 copies sold monthly), Senioren Ratgeber [Guide for the Elderly] (1,702,317 copies sold monthly), Ärztlicher Ratgeber [Medical Guide] (published three times per year with 250,540 copies distributed annually) medizini [medicini – a medical magazine for children] (1,389,192 copies sold monthly), and HausArzt PatientenMagazin [Family Doctor Patient Magazine] (published four times per year with 388,550 copies sold annually).

news-48 Wed, 17 Oct 2018 09:54:16 +0200 Taking responsibility NOVENTI Group is excited about bees and supports biodiversity The number of bee colonies in Germany has fallen drastically in the past 50 years. This has far-reaching consequences because bees are an important factor in our ecosystem. The NOVENTI Group is actively advocating against extinction of species and is offering 12 bee colonies a new home on the business premises of its companies at six locations. Throughout the year, these hard-working bees produce approximately 180 kilograms of bee honey. The Munich-based NOVENTI Group has gained an experienced cooperation partner with the environmental initiative Beefuture for conservation and species protection. Beefuture is establishing the bee colonies and taking care of them. Close cooperation with the initiative is another step towards a comprehensive overall Group strategy in the area of corporate social responsibility (CSR) that will be consistently implemented in the coming years.

"The establishment of the bee colonies is providing an important contribution to species protection and is sending a clear signal about preserving biological diversity. Along with our partner Beefuture, we would like to help protect native plants and animals and also make a positive contribution to the climate footprint of our Group," emphasizes Dr. Hermann Sommer, chief executive officer of NOVENTI Health SE. Cooperation with the environmental initiative is a component of the NOVENTI sustainability strategy. "As an international healthcare company, multi-generational management is a top priority for us. Sustainable behavior is deeply rooted into our entire group. We will also take more actions to protect our environment and the well-being of our employees in the coming years."

The role of bees in our ecosystem and agriculture is often underestimated. After cattle and swine, bees are the third most important type of livestock and directly or indirectly contribute to one third of the global food production because of crop pollination. Pesticides, monocultures, and dwindling sources of food are threatening bees that are actually very robust, adaptable insects and are reducing the amount of bees at an alarming rate. Bee decline has devastating effects on our ecosystem. This is why the NOVENTI Group would like to make a contribution to preserving insect diversity. Initially, the honey that is extracted will be given to the employees of the NOVENTI Group.

news-46 Wed, 19 Sep 2018 09:12:04 +0200 Cooperation between NOVENTI and ARZ Darmstadt: The pharmacy app for Germany Joint press release with ARZ Darmstadt GmbH

NOVENTI and ARZ Darmstadt have signed a cooperation agreement that will promote the launch of a standardized pharmacy app for all German pharmacies with the goal of establishing THE German pharmacy APP on the market. Both companies are combining their free pharmacy apps and thus the further development of the apps so that the two apps callmyApo and Apojet can work on a mutual technological basis. This makes the two current leading apps on the market fully compatible for their approximately 4000 pharmacy users. It is also possible via both apps to use standardized digital access to pharmacies. The two companies are providing the innovative apps for free to all German pharmacies in the interest of safeguarding the future of local pharmacies in Germany. The apps can be used by all pharmacies and their customers throughout the country. This means that today several million people can already use the pharmacy app. Users do not have to switch in the user interface and operation. The apps will be able to be used on a centralized base, and the way for THE German pharmacy APP will be promoted with great strides by joint technical adaptations.

Dr. Hermann Sommer, chairman of the NOVENTI Health SE Management Board: "callmyApo and Apojet are currently the leading pharmacy apps in the German market. The market leadership of these apps will once again be clearly expanded by the cooperation. We are sure that together we are setting a new standard for digital access to pharmacies." Reiner Haupt, managing director of ARZ Darmstadt, "The concept of a standardized pharmacy app for all of Germany is finding great support among pharmacists and shows us that we are on the right path. We are pleased about the positive response from all over the country."

With their pharmacy apps, NOVENTI and ARZ Darmstadt are helping pharmacies provide more customer service and are combining the digital world with the expertise of on-site pharmacies. Local pharmacies can position themselves better as essential partners in health care with a powerful, innovative pharmacy app that is the market leader. This app can put pharmacies at the cutting edge of the digital world and make them available at any time with the decisive advantage of personal, pharmaceutical care in a local pharmacy.

news-40 Mon, 30 Jul 2018 07:54:00 +0200 Björn Zeien comes to the NOVENTI Group NOVENTI brings in expert for cross-sector collaboration Experienced new employee: Bjorn Zeien will boost NOVENTI Health SE as the chief strategy officer (CSO) and help develop and maintain strategic partnerships as of October 1, 2018. Zeien has established and developed successful networks in the healthcare industry in the last 15 years and is now bringing his political and technical expertise to our Group Company in Munich.

Björn Zeien currently works as the head of the Politics and Strategic Networks staff unit in the opta data Group Company. He also is active as the Chief Executive Officer of the Germany.Health.NETWORKED Registered Association (Verein Deutschland.Gesund.VERNETZT. e.V.) as well as the Co-initiator of Essen.Health. NETWORKED (Essen.Gesund.VERNETZT). He acts as a member of the Senate of Economy and was selected for the Institute Board of the Institute of the Future Healthcare Industry. His professional focus is entirely on cross-sector networking at the political and technical level. Zeien is a proven healthcare expert, and the move to NOVENTI is a new challenge that he is excited to take on. A key element in this process is holistic action including new technologies and digital solutions.

He was given the DAK award in 2016 for special dedication to the field of digitization in healthcare.

"Björn Zeien strengthens our position as a digital driver of innovation to interact with lawmakers, scientists, and business. He is a leading expert in the healthcare industry who always uses his knowledge and ability with customers in mind," says Dr. Hermann Sommer, chief executive officer of NOVENTI Health SE. Dr. Sommer is convinced that with Zeien another milestone will be able to be set for the Group Company.


news-39 Tue, 26 Jun 2018 15:39:00 +0200 Advisory Board meeting and FSA Representative Committee NOVENTI Group records a successful 2017 fiscal year At the third ordinary Advisory Board meeting in Augsburg, NOVENTI’s Supervisory Board and senior management reported on the past 2017 fiscal year. The company gave a positive summary in view of the persistently challenging market environment in the healthcare industry. NOVENTI is continuing its stable growth course and ended the 2017 fiscal year with another increase of all important figures. In addition to strong economic growth, the company made notable accomplishments in 2017 as well. The focus of the accomplishments was an expansion of our extensive range of services that the Group is using to continue to clear the way to patient-oriented networking in the German and international health care market.

The NOVENTI Group is continuing its restructuring process that it launched about two years ago to make a synergy network of more than 20 subsidiaries and holdings. The company’s financial position, earnings position and changes in the financial position showed a positive trend in 2017 as well in spite of the associated investments. With annual sales of 156.4 million euros and net income of 21.5 million euros, NOVENTI is securing its top position among the leading international providers of billing services in the healthcare industry. The profit distribution based on capital contributions for the members of FSA Registered Association – the sole shareholder of NOVENTI – was 12 percent. Managing Director, Hermann Sommer, regards the company group as optimally prepared for the challenges of the future and not only because of the satisfying economic situation, “You can only help in a targeted way if you see the whole picture. With this in mind, we provide the right answers to the core issues of the healthcare market as a holistically focused healthcare service provider – as a go-between for lawmakers, business, and society.” His colleague in senior management, Dr. Sven Jansen, adds, “We are organizing healthcare, and that makes us strong. As a market leader, we primarily understand our role as an obligation to offer our customers the highest quality overall approach and as an obligation to set trends as an initiator.”

Strong markets, strong growth
In its core markets, the NOVENTI Group looks back at an eventful year that was marked by a series of milestones. VSA celebrated an important anniversary in April 2017: 50 years of digital prescription billing. In 1967, the company made its first digital billing. Since then, NOVENTI subsidiaries in the pharmacy market have been consistently using technical advances to continually optimize their billing processes. The conditions for innovative developments are also generally positive in the care market: digitization in the care market is going faster than previously assumed. The NOVENTI subsidiary BoS&S LLC wants to use the advantages of this to make more efficient use of what are generally very limited resources in the care industry to be able to meet the growing need for care. With notable success: BoS&S LLC was able to achieve a sales increase of 2 million euros in 2017.

Europe’s largest billing company: NOVENTI HealthCare LLC

The segment of other service providers is important for the company group and is also in a phase of profound change. The main challenges are structural changes from the quickly advancing digitization, growing bureaucracy, mounting cost pressure, and increasing competition. The subsidiaries azh, zrk, and SRZH that operate successfully in this area were merged into the new company NOVENTI HealthCare LLC in 2017 as a reaction to these challenges. Together, these brands serve significantly more than 26,000 customers and have a market share of approximately 22 percent with annual sales of around 51 million euros.

The position of NOVENTI HealthCare LLC was strengthened again in May of this year. Three high-performance pharmacy billing centers from the NOVENTI company group were merged with ALG, SARZ, and VSA under the umbrella of NOVENTI HealthCare LLC. Our new company is now one of the most important providers for billing services in the healthcare industry on an international level with more than 33,500 customers, a transaction volume of around 19 billion euros, and over 1,000 employees. Financial services complete NOVENTI HealthCare LLC’s portfolio. Our current license from the German Federal Financial Supervisory Authority (BaFin) is the key to financial services. Because of our license, innovative, new billing products such as “sofortGeld” (immediate money) can be offered to pharmacy market customers.

Firmly focused on digitization
Digitization is going strong in all areas of our society and economy and will also fundamentally change the healthcare industry in the coming years. According to expert estimates, the worldwide market volume of the digital healthcare market will more than double by the year 2020 to over 200 billion euros. NOVENTI is well prepared for this development and has set the parameters for innovation at an early stage. The Group supports its customers with developing digital business models and considers itself an important link between the real and digital world.

2018 Outlook
For 2018, the senior management is expecting the profitable growth course to continue and is counting on a good overall result in the corporate group. “The NOVENTI Group is well positioned for the future since it has entered into new, digital business segments and included financial services. I’m glad that the Group is setting a trend from a position of strength for the technological and societal change in the healthcare industry,” says Supervisory Board Chairman Uwe Geiss in the name of the NOVENTI Supervisory Board. FSA Chief Executive Officer Jürgen Frasch is also optimistic, “As a company owned by pharmacists, NOVENTI is setting new standards in the area of digitization and is strengthening the role of German pharmacists in the healthcare industry. The Group is creating extensive digital access to on-site pharmacies using the pharmacy order app callmyApo. This service is even free for members of the pharmacist associations.” The Advisory Board and the Representative Committee formally approved of the actions of all members of the Supervisory Board and the FSA Executive Board for fiscal year 2017.

Hans-Joachim Niermann named as an honorary member of FSA
FSA Registered Association is the sole shareholder of NOVENTI. At the 37th ordinary Representative Committee meeting, First Chairman Jürgen Frasch named long-time Executive Board member Hans-Joachim Niermann as an honorary member. By doing so, the Executive Board honored Niermann’s achievements and loyalty. Niermann has served on FSA boards since the year 2000. He was an Executive Board member from 2002 to 2015, and starting in 2011 he held the office of second chairman.

news-38 Tue, 15 May 2018 09:08:26 +0200 NOVENTI Group founds Europe’s largest billing company in the healthcare industry and combines pharmacy billing centers under one roof ALG, SARZ, and VSA as future brands of NOVENTI HealthCare LLC The healthcare market is in a state of change, and the NOVENTI Group is reacting to the challenges in its core markets. ALG, SARZ, and VSA make the Group Company the market leader in the field of pharmacy billing centers. The Group Company is now building strength: the three pharmacy billing centers will be combined under the roof of NOVENTI HealthCare LLC in the future. This will make it Europe’s largest billing company in the healthcare industry with a billing volume of 19 billion.

With a billing volume of more than 15 billion euros, the pharmacy billing centers ALG, SARZ, and VSA are already an important financial partner for the customers of the NOVENTI Group. The Group’s position is being systematically strengthened by expanding the range of services and products in the area of “billing and finances.” A license from the German Federal Financial Supervisory Authority (BaFin) is an important requirement for this step. This license has already been obtained for NOVENTI HealthCare LLC and its brands azh, SRZH, and zrk within the NOVENTI Group. The “new” NOVENTI HealthCare LLC is now one of the most important providers for billing services in the healthcare industry on an international level with more than 33,500 customers, a transaction volume of around 19 billion euros, and 1,000 employees.

NOVENTI Managing Director Dr. Hermann Sommer explains the circumstances of the decision: "Combining our very successful pharmacy billing centers, emphasizes the excellent market position of the entire NOVENTI Group as a systemically relevant provider in the healthcare market. We are also taking advantage of the current opportunities to design the processes and standards for tomorrow. The company mergers should be finished by the end of June 2018. This makes it possible for NOVENTI HealthCare LLC to introduce new, innovative billing products even on a grand scale such as ‘sofortGeld’ (immediate money) to customers in the pharmacy market."

The management of the new NOVENTI HealthCare LLC will consist of Susanne Hausmann, Victor Castro, André Dietmann, and Roman Schaal.


news-37 Fri, 06 Apr 2018 02:01:00 +0200 NOVENTI will introduce new trends for the digital healthcare industry at the conhIT 2018 The NOVENTI Group will discuss the future of the market with companies and associations as well as decision-makers from government, healthcare, business, and industry at the leading European tradeshow in the industry, the conhIT 2018 in Berlin. From April 17-19, 2018, the company will be providing information about its own newest developments (Hall 1.2, Stand A-110). This includes the new products vimedi, the digital prescription collection point, and the newest innovations for care software.

vimedi stands for the medication management of the future and is an interactive app from our subsidiary NOVENTI Digital. This app allows users to create individual medication plans and to have close interaction with their trusted pharmacy. It can be used intuitively, it makes it easier for patients to monitor their most important health information at any time, and indicates side effects and interactions. VSA is a NOVENTI company that is breaking new, digital ground. It is the market leader for prescription billing and is presenting the new digital prescription collection point to help on-site pharmacies with local supply. The focus is on innovative mobile device management (MDM) and mobile care documentation in the field of care software from the NOVENTI company BoS&S. Innovative mobile device management and mobile care documentation along with the current care cell phone XCover 4 from SAMSUNG make the everyday work of care workers easier and safer.

The experts of the NOVENTI Group will explain these solutions and more to interested conhIT 2018 attendees at the NOVENTI stand. "At the tradeshow, we will focus on topics such as patient-centered care, networking, and digital transformation as well as the associated convention," says Managing Director Dr. Sven Jansen. As a provider of IT solutions and services for the healthcare industry, the company is at the crossroads of these areas and creates innovative, digital solutions and applications that meet the growing demands of the market. "The conhIT informational websites and platforms give us the fresh momentum to continue to be able to push our work forward," Dr. Sven Jansen continues. "We are very much looking forward to the inspiring interaction with other industry representatives at the conhIT."


news-36 Mon, 18 Dec 2017 11:07:51 +0100 NOVENTI Group Managing Director Peter Mattis retires An impressive career: after 21 years Managing Director Peter Mattis is leaving the NOVENTI Group Company in Munich at the end of the year and is taking a well-deserved retirement. Peter Mattis looks back on a successful career at the age of 60. Under his leadership, the NOVENTI Group (formerly the VSA Group Company) grew from VSA, a regional prescription biller, to one of the most important actors on the German health care market. By April 1, 2017, the Supervisory Board had decided on Dr. Sven Jansen as the successor of Peter Mattis and his Co-managing Director Dr. Hermann Sommer.

The success story of the NOVENTI Group is also the story of Peter Mattis. As a forward thinker and strategist, he decisively paved the Group Company’s way to being an innovative and also financially successful driving force in the healthcare industry. In January 1997, Mattis succeeded long-time company executive Dr. Herbert Reber at VSA and jointly managed VSA with Dr. Andreas Lacher until the end of 2015. Mattis recognized the opportunities of digitization at a very early stage and the market requirements for comprehensive services. VSA was expanded from a regional billing center to an integrated software and billing company under his management. When the holding in what was then called Dr. Ing. Stahl LLC and CSE Stock Corporation was acquired in 1998, VSA expanded its business sector to the area of pharmacy software, which now is successfully represented by the market leader awinta. It was a strategically important decision and the beginning of the current company architecture.

Another important milestone in Mattis’ career was founding the new NOVENTI parent company as a logical reaction to the constant growth of the entire VSA Group Company. It is also to Mattis’ credit that the NOVENTI Group today is economically sound, is growing sustainably, and is consistently expanding its target groups. This can be seen by expansion in the area of prescription billing for pharmacies by purchasing ALG LLC, in the area of prescription billing and industry software for other service providers with the azh and SRZH brands, the entry into the care market by taking over majority shares in BoS&S LLC, or most recently by founding NOVENTI Digital as part of the digitization strategy.

"Peter Mattis significantly pushed the constant advancement of NOVENTI with his clear, analytical, and even sometimes critical view as a thinker and director. The NOVENTI Group is so stable today thanks to his openness to innovative technologies, his creativity and determination, his untiring effort, and his absolute loyalty and integrity," says FSA Chief Executive Officer Jürgen Frasch. NOVENTI Chairman of the Supervisory Board Uwe Geiss adds, "Now that Peter Mattis is leaving us, we are not only losing a recognized expert in the healthcare market, but also a coworker and person who was highly appreciated by everyone."